Patent · US Active

Vaccines for control of epidemic Aeromonas hydrophila generated by markerless gene deletion

US9492521B2 · kind B2 · utility

0Cited by
1References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 28, 2015
Grant dateNov 15, 2016
Priority date
Expiry dateMay 28, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/552
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are attenuated bacteria, compositions comprising attenuated bacteria, and vectors and methods for preparing attenuated bacteria. The attenuated bacteria may include attenuated Aeromonas hydrophila for use in vaccinating aquatic animals such as channel catfish against Motile Aeromonas Septicemia (MAS).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.